Cote d'Ivoire vs Croatia: The number of people with susceptibility test result for rifampicin
Cote d'Ivoire
59.19
in 2021
Croatia
60.19
in 2021
Cote d'Ivoire rank
111th
Croatia rank
109th
The number of people with susceptibility test result for rifampicin over time
- Cote d'Ivoire
- Croatia
How they compare
Croatia currently reports 60.19 against 59.19 in Cote d'Ivoire, a difference of 1.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Croatia ahead.
Cote d'Ivoire ranks 111th and Croatia ranks 109th of 146 countries.
Across the 2 decades both report, Cote d'Ivoire averaged higher in 1 and Croatia in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Croatia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.43 | 70.15 | 46.72 | Croatia |
| 2020s | 34.58 | 30.1 | 4.48 | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Croatia?
- Croatia, at 60.19 against 59.19 in Cote d'Ivoire as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Croatia?
- 1, with Croatia ahead.
- How many years of comparable data are there for Cote d'Ivoire and Croatia?
- 5 years are reported by both, from 2017 to 2021.
- How do Cote d'Ivoire and Croatia rank globally for the number of people with susceptibility test result for rifampicin?
- Cote d'Ivoire ranks 111th and Croatia ranks 109th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.